Preview

Кардиоваскулярная терапия и профилактика

Расширенный поиск

Синдром обструктивного апноэ сна как независимый фактор риска развития сердечно-сосудистых осложнений

Полный текст:

Аннотация

В настоящее время накоплены доказательства независимости взаимосвязи между синдромом обструктивного апноэ сна (СОАС) и сердечно-сосудистыми заболеваниями (ССЗ). Особенно это характерно для артериальной гипертонии (АГ), ишемической болезни сердца (ИБС), инсультов (МИ), сердечной недо­статочности, мерцательной аритмии и внезапной сердечной смерти. В связи с этим настоящий обзор представляется достаточно актуальным, т. к. посвящен взаимоотношениям между СОАС и такими ССЗ, как АГ, ИБС, МИ, сахарный диабет и смертность.

Об авторах

М. Н. Болотова
Институт клинической кардиологии им. А.Л. Мясникова, ФГУ “РКНПК”
Россия

Аспирант отдела системных гипертензий.

Москва 



П. В. Галицин
Институт клинической кардиологии им. А.Л. Мясникова, ФГУ “РКНПК”
Россия

Младший научный сотрудник этого же отдела.

Москва



И. П. Колос
Институт клинической кардиологии им. А.Л. Мясникова, ФГУ “РКНПК”
Россия

Научный сотрудник отдела возрастных проблем сердечно-сосудистых заболеваний.

Москва



А. Ю. Литвин
Институт клинической кардиологии им. А.Л. Мясникова, ФГУ “РКНПК”
Россия

Старший научный сотрудник отдела системных гипертензий.

Москва



И. Е. Чазова
Институт клинической кардиологии им. А.Л. Мясникова, ФГУ “РКНПК”
Россия

Руководитель отдела системных гипертензий.

Москва



Список литературы

1. American Academy of Sleep Medicine (AASM). International Classification of Sleep Disorders. Westchester, AASM, 2005.

2. Akashiba T, Kawahara S, Akahoshi T, et al. Relationship between quality of life and mood or depression in patients with severe obstructive sleep apnea syndrome. Chest 2002; 122: 861—5.

3. 3.Schwartz DJ, Kohler WC, Karatinos G. Symptoms of depression in individuals with obstructive sleep apnea may be amenable to treatment with continuous positive airway pressure. Chest 2005; 128: 1304-9.

4. Phillips B. Sleep-disordered breathing and cardiovascular disease. Sleep Med Rev 2005; 9: 131-40.

5. Giles TL, Lasserson TJ, Smith BJ, et al. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006; 3: CD001106.

6. Tarasiuk A, Greenberg-Dotan S, Brin YS, et al. Determinants affecting health-care utilization in obstructive sleep apnea syndrome patients. Chest 2005; 128: 1310-4.

7. Ayas NT, Fitzgerald JM, Fleetham JA, et al. Costeffectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea. Arch Intern Med 2006; 166: 977-84.

8. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-5.

9. Tishler PV, Larkin EK, Schluchter MD, Redline S. Incidence of sleep disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep- disordered breathing. JAMA 2003; 289: 2230-7.

10. Newman AB, Foster G, Givelber R, et al. Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study. Arch Intern Med 2005; 165: 2408-13.

11. Young T, Peppard PE, Taheri S. Excess weight and sleepdisor- dered breathing. J Appl Physiol 2005; 99: 1592-9.

12. Villanueva AT, Buchanan PR, Yee BJ, Grunstein RR. Ethnicity and obstructive sleep apnoea. Sleep Med Rev 2005; 9: 419-36.

13. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep- disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001; 163: 608-13.

14. European Science Foundation. COST program website. www.cost.esf.org. Date last updated: August 2001.

15. Marrone O, Bonsignore MR. Pulmonary haemodynamics in obstructive sleep apnoea. Sleep Med Rev 2002; 6: 175-93.

16. Lugaresi E, Cirignotta F, Coccagna G, Piana C. Some epidemiological data on snoring and cardiocirculatory disturbances. Sleep 1980; 3: 221-4.

17. Pendlebury ST, Pepin JL, Veale D, Levy P. Natural evolution of moderate sleep apnoea syndrome: significant progression over a mean of 17 months. Thorax 1997; 52: 872-8.

18. Zaninelli A, Fariello R, Boni E, et al. Snoring and risk of cardio¬vascular disease. Int J Cardiol 1991; 32: 347-51.

19. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middleaged men with obstructive sleep apnea: a 7-year followup. Am J Respir Crit Care Med 2002; 166: 159-65.

20. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardio¬vascular outcomes in men with obstructive sleep apnoea-hypo-pnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-53.

21. Doherty LS, Kiely JL, Swan V, McNicholas WT. Longterm effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005; 127: 2076-84.

22. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25: 735-41.

23. Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353: 2034-41.

24. He J, Kryger MH, Zorick FJ, et al. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 1988; 94: 9-14.

25. Lavie P, Lavie L, Herer P. All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur Respir J 2005; 25: 514-20.

26. Veale D, Chailleux E, Hoorelbeke-Ramon A, et al. Mortality of sleep apnoea patients treated by nasal continuous positive airway pressure registered in the ANTADIR observatory. Association Nationale pour le Traitement A Domicile de l’Insuffisance Respiratoire chronique. Eur Respir J 2000; 15: 326-31.

27. Campos-Rodriguez F, Pena-Grinan N, Reyes-Nunez N, et al. Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 2005; 128: 624-33.

28. Seppa la T, Partinen M, Penttila A, Aspholm R, Tiainen E, Kaukianen A. Sudden death and sleeping history among Finnish men. J Intern Med 1991; 229: 23-8.

29. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005; 352: 1206-14.

30. Lattimore JL, Celermajer DS, Wilcox I. Obstructive sleep apnea and cardiovascular disease. JACC 2003; 41: 429-37.

31. Davies CW, Crosby JH, Mullins RL, Barbour C, Davies RJ, Stradling JR. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 2000; 55: 736-40.

32. Hedner J, Bengtsson-Bostroom K, Peker Y, et al. Hypertension prevalence in obstructive sleep apnoea and sex: a population- based case-control study. Eur Respir J 2006; 27: 1-7.

33. Wright JT Jr, Redline S, Taylor AL, et al. Relationship between 24-h blood pressure and sleep disordered breathing in a normo-tensive community sample. Am J Hypertens 2001; 14: 743-8.

34. Dhillon S, Chung SA, Fargher T, Huterer N, Shapiro CM. Sleep apnea, hypertension, and the effects of continuous positive airway pressure. Am J Hypertens 2005; 18: 594-600.

35. Norman D, Loredo JS, Nelesen RA, et al. Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 2006; 47: 840—5.

36. Baguet JP, Hammer L, Levy P, et al. Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens 2005; 23: 521—7.

37. Baguet J, Narkiewicz K, Mallion J. Update on hypertension management: obstructive sleep apnea and hypertension. J Hypertens 2006; 24: 205-8.

38. Haas DC, Foster GL, Nieto FJ, et al. Age-dependent associations between sleep-disordered breathing and hypertension. Circulation 2005; 111: 614-621.

39. Sin DD, Fitzgerald F, Parker JD, et al. Relationship of systolic BP to obstructive sleep apnea in patients with heart failure. Chest 2003; 123: 1536-43.

40. Planes C, Leroy M, Fayet G, et al. Exacerbation of sleep-apnoea related nocturnal blood pressure fluctuations in hypertensive subjects. Eur Respir J 2002; 20: 151-7.

41. Arias MA, Garcia-Rio F, Alonso-Fernadez A, et al. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 2005; 112: 375-83.

42. Peker Y, Kraiczi H, Hedner J, et al. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 1999; 14: 179-84.

43. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease. Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163: 19-25.

44. Bonsignore MR, Smirne S, Marrone O, Insalaco G, Salvaggio A, Bonsignore G. Myocardial ischemia during sleep. Sleep Med Rev 1999; 3: 241-55.

45. Peker Y, Hedner J, Kraiczi H, Lo th S. Respiratory disturbance index. An independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000; 162: 81-6.

46. Milleron O, Pilliere R, Foucher A, et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 2004; 25: 728-34.

47. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006; 28: 596-602.

48. Begum PC, Joyeux-Faure M, Godin-Ribuot D, et al. Acute intermittent hypoxia improves rat myocardium tolerance to ischemia. J Appl Physiol 2005; 99: 1064-9.

49. Alonso-Fernandez A, Garcia-Rio F, Racionero MA, et al. Cardiac rhythm disturbances and ST-segment depression episodes in patients with obstructive sleep-apnea-hypopnea syn¬drome and its mechanisms. Chest 2005; 127: 15-22.

50. Peters RW. Obstructive sleep apnea and cardiovascular disease. Chest 2005; 127: 1-3.

51. Yaggi H, Mohsenin V. Obstructive sleep apnoea and stroke. Lancet Neurol 2004; 3: 333-42.

52. Turkington PM, Elliott MW. Sleep disordered breathing follow¬ing stroke. Monaldi Arch Chest Dis 2004; 61: 157-61.

53. Arzt M, Young T, Finn L, et al. Association of sleep disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005; 172: 1447-51.

54. Elwood P, Hack M, Pickering J, et al. Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort. J Epidemiol Community Health 2006; 60: 69-73.

55. Baguet JP, Hammer L, Levy P, et al. The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest 2005; 128: 3407-12.

56. Selic C, Siccoli MM, Hermann DM, Bassetti CL. Blood pressure evolution after acute ischemic stroke in patients with and without sleep apnea. Stroke 2005; 36: 2614-8.

57. Martinez-Garcia MA, Galiano-Blancart R, Roman-Sanchez P, et al. Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke. Chest 2005; 128: 2123-9.

58. Dziewas R, Humpert M, Hopmann B, et al. Increased prevalence of sleep apnea in patients with recurring ischemic stroke compared with first stroke victims. J Neurol 2005; 252: 1394-8.

59. Kaneko Y, Hajek VE, Zivanovic V, et al. Relationship of sleep apnea to functional capacity and length of hospitalization following stroke. Sleep 2003; 26: 293-7.

60. Bassetti CL, Milanova M, Gugger M. Sleep-disordered breathing and acute ischemic stroke. Diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke 2006; 37: 967-72.

61. Alchanatis M, Deligiorgis N, Zias N, et al. Frontal brain lobe impairment in obstructive sleep apnoea: a proton MR spectros¬copy study. Eur Respir J 2004; 24: 980-6.

62. Dyken ME, Yamada T, Glenn CL, Berger HA. Obstructive sleep apnea associated with cerebral hypoxemia and death. Neurology 2004; 62: 491-3.

63. Caples SM, Wolk R, Somers VK. Influence of cardiac function and failure on sleep-disordered breathing: evidence for a causative role. J Appl Physiol 2005; 99: 2433-9.

64. Arzt M, Bradley TD. Treatment of sleep apnea in heart failure. Am J Respir Crit Care Med 2006; 173: 1300-8.

65. Sin DD, Fitzgerald F, Parker JD, et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999; 160: 1101-6.

66. Javaheri S. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol 2006; 106: 21-8.

67. Laaban J-P, Pascal-Sebaoun S, Bloch E, et al. Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest 2002; 122: 1133-8.

68. Roebuck T, Solin P, Kaye DM, et al. Increased long-term mortality in heart failure due to sleep apnoea is not yet proven. Eur Respir J 2004; 23: 735-40.

69. Ancoli-Israel S, DuHamel ER, Stepnowsky C, et al. The relationship between congestive heart failure, sleep apnea, and mortality in older men. Chest 2003; 124: 1400-5.

70. Adlakha A, Shepard JW Jr. Cardiac arrhythmias during normal sleep and in obstructive sleep apnea syndrome. Clin Chest Med 1992; 13: 437-58.

71. Becker HF, Koehler U, Stammnitz A, Peter JH. Heart block in patients with sleep apnoea. Thorax 1998; 53(Suppl. 3): S29-32.

72. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnoea syndrome. Am J Cardiol 1983; 52: 490-4.

73. Koehler U, Becker HF, Grimm W, et al. Relations among hypoxemia, sleep stage, and bradyarrhythmia during obstructive sleep apnoea. Am Heart J 2000; 139: 142-8.

74. Koehler U, Fus E, Grimm W, et al. Heart block in patients with obstructive sleep apnoea: pathogenetic factors and effects of treatment. Eur Respir J 1998; 11: 434-9.

75. Simantirakis EN, Schiza SI, Marketou ME, et al. Severe bradyar- rhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment. Eur Heart J 2004; 25: 1070-6.

76. Stegman SS, Burroughs JM, Henthorn RW Asymptomatic bra-dyarrhythmias as a marker for sleep apnea: appropriate recognition and treatment may reduce the need for pacemaker therapy. Pacing Clin Electrophysiol 1996; 19: 899-904.


Для цитирования:


Болотова М.Н., Галицин П.В., Колос И.П., Литвин А.Ю., Чазова И.Е. Синдром обструктивного апноэ сна как независимый фактор риска развития сердечно-сосудистых осложнений. Кардиоваскулярная терапия и профилактика. 2009;8(5):103-112.

For citation:


Bolotova M.N., Golitsyn P.V., Kolos I.P., Litvin A.Y., Chazova I.E. Sleep obstructive apnoea syndrome as an independent cardiovascular risk factor. Cardiovascular Therapy and Prevention. 2009;8(5):103-112. (In Russ.)

Просмотров: 101


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)